MedMira Cash Flow | StatInvestor

Health Care & Life Sciences » Medical Equipment & Supplies | MedMira Inc.

MedMira Inc. | Cash Flow

Fiscal year is August-July. All values CAD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

3,499.60

5,158.40

2,661.10

2,509.50

Depreciation, Depletion & Amortization

94.10

99.80

98.80

66.80

Other Funds

402.80

270.00

200.00

1,310.10

69.50

Funds from Operations

2,087.80

4,567.80

2,901.70

4,727.70

2,455.70

2,373.20

Changes in Working Capital

285.40

635.20

565.40

1,577.70

Net Operating Cash Flow

2,087.80

4,567.80

2,616.30

4,092.60

1,890.30

795.40

Capital Expenditures

367.00

96.30

27.20

Sale of Fixed Assets & Businesses

0.30

Net Investing Cash Flow

367.00

96.30

27.20

0.30

Issuance/Reduction of Debt, Net

461.30

691.20

258.80

1,271.50

689.70

Net Financing Cash Flow

58.50

4,851.70

2,716.30

3,903.50

1,999.80

Net Change in Cash

2,395.90

141.50

99.90

216.30

109.80

Free Cash Flow

2,454.80

4,664.10

2,616.30

4,119.80

1,890.30

Change in Capital Stock

5,542.90

2,187.50

4,975.00

Exchange Rate Effect

0.50

46.20

About MedMira

View Profile

Address	155 Chain Lake Drive Halifax Nova Scotia B3S 1B3 Canada
Employees	-
Website	http://www.medmira.com
Updated	07/08/2019
MedMira, Inc. engages in the research, development, manufacture, and commercialization of rapid diagnostics and technology platforms. Its tests provide hospitals, labs, clinics, and individuals with rapid diagnosis for diseases, including human immunodeficiency virus and hepatitis C. It offers its tests under the Reveala, Multiplo, and Miriad brands.